Pressmeddelanden, rapporter och bolagsmeddelande för Curasight

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Resolutions of the Annual General Meeting of Curasight A/S
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Notice of Annual General Meeting 2023
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Annual Report for the fiscal year 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Reports: Year-end report October - December 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight to present at HC Andersen Capital
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight to present at Redeye Fight Cancer Seminar
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Reports: Interim Report January – September 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight to present at HC Andersen Capital
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight to present at SEB Healthcare Seminar 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Curasight

Press release from Companies: Curasight initiates pre-clinical studies with uTREAT[®] therapy in head and neck cancer (HNSCC) and neuroendocrine tumors (NET)